Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Enanta Pharmaceuticals (DE:9EP)
FRANKFURT:9EP
RESEARCH TOOLSreports
Holding DE:9EP?
Track your performance easily
Recent Insider Trading Activity
Date | Name | Activity | Value |
|---|---|---|---|
| Dec 15, 2023 | Terry Vance Director | xxxxxxxxxxxxx | $139490 |
| Dec 06, 2023 | xxxxxxxxxxxxx | $5142 | |
| Dec 06, 2023 | Tara Lynn Kieffer Chief Product Strategy Officer | xxxxxxxxxxxxx | $20464 |
| Dec 06, 2023 | xxxxxxxxxxxxx | $23228 |
Top Shareholders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 2,095,000 | Institution | 9.89% | 21,702,105 | |
| 1,074,224 | Institution | 5.07% | 11,127,886 | |
| 911,208 | Institution | 4.30% | 9,439,204 | |
| 811,845 | Institution | 3.83% | 8,409,902 | |
| 810,609 | Insider | 3.83% | 7,538,664 | |
| 451,416 | Institution | 2.13% | 4,676,218 | |
| 373,295 | Insider | 1.76% | 3,471,644 | |
| 229,925 | Institution | 1.09% | 2,381,793 | |
| 200,427 | Institution | 0.95% | 2,076,223 | |
| 172,358 | Institution | 0.81% | 1,785,457 |
Top Mutual Fund Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 911,208 | Institution | 4.30% | 9,439,204 | |
| 451,416 | Institution | 2.13% | 4,676,218 | |
| 229,925 | Institution | 1.09% | 2,381,793 | |
| 200,427 | Institution | 0.95% | 2,076,223 | |
| 172,358 | Institution | 0.81% | 1,785,457 | |
| 166,553 | Institution | 0.79% | 1,725,323 | |
| 147,827 | Institution | 0.70% | 1,531,340 | |
| 137,615 | Institution | 0.65% | 1,425,554 | |
| 119,191 | Institution | 0.56% | 1,234,700 | |
| 118,106 | Institution | 0.56% | 1,223,460 |
Top ETF Holders
Holder | # of Shares | Type | % Holding | Value |
|---|
FAQ
Who Owns Enanta Pharmaceuticals (DE:9EP)?
Currently, no data Available
What percentage of Enanta Pharmaceuticals (DE:9EP) stock is held by institutional investors?
Currently, no data Available
What percentage of Enanta Pharmaceuticals (DE:9EP) stock is held by retail investors?
Currently, no data Available
Who owns the most shares of Enanta Pharmaceuticals (DE:9EP)?
Andrew J.M. Spokes owns the most shares of Enanta Pharmaceuticals (DE:9EP).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.